| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
BMY
Bristol-Myers Squibb
|
Oct 13, 2025 | HOLD |
Buy
+8.2% avg upside
42 analysts
|
— | +26.8% |
|
OCUL
Ocular Therapeutix
|
Aug 04, 2025 | BUY |
Strong Buy
+149.9% avg upside
21 analysts
|
$19.00
101.52% Upside
|
-19.3% |
|
CYTK
Cytokinetics
|
Apr 02, 2025 | BUY |
Strong Buy
+8.2% avg upside
36 analysts
|
$81.00
2.81% Upside
|
+65.8% |
|
RVMD
Revolution Medicines
|
Nov 15, 2023 | BUY |
Strong Buy
-13.2% avg upside
32 analysts
|
$30.00
81.52% Downside
|
+158.3% |
|
REGN
Regeneron
|
Nov 02, 2023 | BUY |
Strong Buy
+26.8% avg upside
57 analysts
|
$950.00
55.78% Upside
|
+3.0% |
|
NKTX
Nkarta
|
Oct 17, 2023 | BUY |
Strong Buy
+561.5% avg upside
15 analysts
|
$13.00
354.49% Upside
|
+27.4% |
|
BBIO
BridgeBio Pharma
|
Jul 18, 2023 | BUY |
Strong Buy
+35.5% avg upside
34 analysts
|
$46.00
30.51% Downside
|
-20.3% |
|
LKFT
Lakefront Biotherapeutics
|
May 05, 2023 | BUY |
Hold
+266.6% avg upside
24 analysts
|
$69.00
143.74% Upside
|
· |
|
RGNX
RegenXBio
|
May 03, 2023 | BUY |
Strong Buy
+341.8% avg upside
22 analysts
|
$65.00
733.34% Upside
|
-16.8% |
|
RLAY
Relay Therapeutics
|
Apr 19, 2023 | BUY |
Strong Buy
+20.8% avg upside
19 analysts
|
$29.00
82.71% Upside
|
-51.7% |
|
AMGN
Amgen
|
Apr 17, 2023 | HOLD |
Buy
-12.8% avg upside
57 analysts
|
— | +10.0% |
|
SLP
Simulations Plus
|
Apr 05, 2023 | BUY |
Buy
+90.5% avg upside
11 analysts
|
$70.00
283.86% Upside
|
+14.7% |
|
LIANY
LianBio Sponsored ADR
|
Mar 28, 2023 | BUY |
Buy
+11065.9% avg upside
4 analysts
|
$15.00
13462.39% Upside
|
· |
|
ALLO
Allogene Therapeutics
|
Feb 28, 2023 | HOLD |
Strong Buy
+634.9% avg upside
28 analysts
|
— | -19.4% |
|
CMPX
Compass Therapeutics
|
Jan 20, 2023 | BUY |
Strong Buy
+363.0% avg upside
19 analysts
|
— | +1097.8% |
|
XLO
Xilio Therapeutics
|
Dec 01, 2022 | BUY |
Strong Buy
+93.2% avg upside
7 analysts
|
$13.00
47.83% Upside
|
-56.5% |
|
XNCR
Xencor
|
Nov 08, 2022 | BUY |
Strong Buy
+144.9% avg upside
27 analysts
|
$58.00
358.81% Upside
|
-41.2% |
|
CRIS
Curis
|
Apr 04, 2022 | HOLD |
Strong Buy
+1957.4% avg upside
12 analysts
|
— | -64.2% |
|
VYGR
Voyager Therapeutics
|
Mar 22, 2022 | HOLD |
Strong Buy
+283.4% avg upside
23 analysts
|
— | -13.3% |
|
TARS
Tarsus Pharmaceuticals
|
Oct 07, 2021 | BUY |
Strong Buy
+19.8% avg upside
16 analysts
|
$65.00
2.94% Upside
|
-24.6% |
|
DNLI
Denali Therapeutics
|
Jul 25, 2021 | HOLD |
Strong Buy
+57.0% avg upside
24 analysts
|
— | -34.7% |
|
LCTX
Lineage Therap
|
Mar 11, 2021 | HOLD |
Strong Buy
+334.2% avg upside
16 analysts
|
— | -42.7% |
|
DNTH
Dianthus Therapeutics
|
Jun 11, 2020 | BUY |
Strong Buy
+3.4% avg upside
29 analysts
|
$15.00
81.82% Downside
|
+28.1% |
|
MGNX
MacroGenics
|
Sep 10, 2018 | BUY |
Buy
+297.0% avg upside
25 analysts
|
$30.00
626.42% Upside
|
-32.2% |
|
JNJ
Johnson & Johnson
|
May 21, 2018 | SELL |
Strong Buy
-4.4% avg upside
36 analysts
|
$110.00
51.93% Downside
|
-14.7% |
|
VRTX
Vertex Pharmaceuticals
|
Apr 26, 2018 | BUY |
Strong Buy
-4.8% avg upside
61 analysts
|
$200.00
55.71% Downside
|
+8.8% |
|
CRVS
Corvus Pharmaceuticals
|
Nov 13, 2017 | BUY |
Strong Buy
+108.8% avg upside
14 analysts
|
$26.00
118.21% Upside
|
-41.1% |
|
ABT
Abbott Laboratories
|
Jun 21, 2017 | BUY |
Strong Buy
+31.8% avg upside
35 analysts
|
$56.00
36.58% Downside
|
+29.7% |
|
ILMN
Illumina
|
Mar 16, 2017 | HOLD |
Buy
-9.9% avg upside
30 analysts
|
— | +59.2% |
|
DHR
Danaher
|
Sep 06, 2016 | BUY |
Strong Buy
+21.4% avg upside
45 analysts
|
$92.00
48.16% Downside
|
+6.4% |
|
TMO
Thermo Fisher
|
May 27, 2016 | HOLD |
Strong Buy
+26.9% avg upside
38 analysts
|
— | +14.4% |
|
A
Agilent
|
May 24, 2016 | BUY |
Strong Buy
+4.0% avg upside
32 analysts
|
$50.00
60.63% Downside
|
+32.9% |
|
BRKR
Bruker
|
May 05, 2016 | HOLD |
Buy
-6.5% avg upside
22 analysts
|
$28.00
50.98% Downside
|
-3.8% |
|
RVTY
Revvity
|
Feb 04, 2016 | HOLD |
Buy
+5.8% avg upside
23 analysts
|
— | +12.6% |
|
MYGN
Myriad Genetics
|
Jun 05, 2014 | HOLD |
Hold
+315.1% avg upside
24 analysts
|
$36.00
692.88% Upside
|
-5.6% |
|
SUN
Sunoco
|
May 08, 2014 | HOLD |
Strong Buy
+2.4% avg upside
12 analysts
|
$40.00
37.10% Downside
|
+21.1% |
|
CASY
Casey's General
|
Feb 21, 2014 | HOLD |
Strong Buy
-23.5% avg upside
27 analysts
|
$70.00
91.78% Downside
|
+37.9% |
|
DGX
Quest Diagnostics
|
Jul 19, 2013 | BUY |
Buy
-12.1% avg upside
33 analysts
|
— | +4.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.